However, it is becoming increasingly important to understand the consequences of Ozempic when used off-label
Antonissen, Gunther, Filip Van Immerseel, Frank Pasmans, Richard Ducatelle, Freddy Haesebrouck, Leen Timbermont, Marc Verlinden, et al
These systemic improvements correlate with reduced infection susceptibility and enhanced immune surveillance capacity in aged individuals
Although glucagon typically raises blood sugar, in the presence of GLP-1 and GIP, the response becomes more balanced, leading to: increased energy expenditure enhanced fat oxidation greater metabolic burn at rest reduction in liver fat prevention of metabolic slowdown during weight loss This combination makes retatrutide particularly effective for individuals who typically plateau on GLP-1 drugs due to metabolic adaptation
Increased risk of low blood sugar (hypoglycemia) in patients with type 2 diabetes, especially those who also take medicines for type 2 diabetes such as sulfonylureas or insulin